← Open Payments lookup

AMANDA HILL: Open Payments

NPI 1194248179 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,021 in 49 payments from 12 companies in 2025. Trend: 2023 $784 · 2024 $843 · 2025 $1,021

Food & beverage: $1,021
CompanyPaymentsAmount
Janssen Biotech, Inc.8$192
Regeneron Healthcare Solutions, Inc.5$145
ABBVIE INC.7$127
Gilead Sciences, Inc.6$111
Phathom Pharmaceuticals, Inc.6$86
Takeda Pharmaceuticals U.S.A., Inc.3$75
Celltrion USA Inc.3$63
Aimmune Therapeutics, Inc.3$58
Intercept Pharmaceuticals, Inc.3$54
GENZYME CORPORATION2$51

Products named: DUPIXENT, TREMFYA, VOQUEZNA, ENTYVIO, MAVYRET, VEGZELMA, ZENPEP, OCALIVA.

Industry payments across OR — which companies pay providers there.